anti-PSMA humabody-deBouganin fusion proteins (Crescendo/Sesen Bio)

N/A

Report date: 2025/03/18 18:05:59

Base Information

Drug Nameanti-PSMA humabody-deBouganin fusion proteins (Crescendo/Sesen Bio)
Drug Alias Namebiparatopic humabody drug conjugate (Crescendo/Eleven)anti-PSMA humabody-deBouganin fusion proteins (Crescendo/Eleven)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment +[4] 
Mechanisms of ActionProstate-Specific Membrane Antigen modulators
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrescendo Biologics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSesen Bio IncCrescendo Biologics Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A